Abstract A168: Hepatitis B virus pre-S2 mutant stimulates aerobic glycolysis through mammalian target of rapamycin signaling in tumorigenesis

MLA

Ih-Jen Su, et al. “Abstract A168: Hepatitis B Virus Pre-S2 Mutant Stimulates Aerobic Glycolysis through Mammalian Target of Rapamycin Signaling in Tumorigenesis.” Molecular Cancer Therapeutics, vol. 12, Nov. 2013, p. A168. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ddc7f52373cf16fab53582ef292074d&authtype=sso&custid=ns315887.

APA

Ih-Jen Su, Hung Wen Tsai, Chiao-Fang Teng, Wen-Chuan Hsieh, & Han Chieh Wu. (2013). Abstract A168: Hepatitis B virus pre-S2 mutant stimulates aerobic glycolysis through mammalian target of rapamycin signaling in tumorigenesis. Molecular Cancer Therapeutics, 12, A168.

Chicago

Ih-Jen Su, Hung Wen Tsai, Chiao-Fang Teng, Wen-Chuan Hsieh, and Han Chieh Wu. 2013. “Abstract A168: Hepatitis B Virus Pre-S2 Mutant Stimulates Aerobic Glycolysis through Mammalian Target of Rapamycin Signaling in Tumorigenesis.” Molecular Cancer Therapeutics 12 (November): A168. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ddc7f52373cf16fab53582ef292074d&authtype=sso&custid=ns315887.